-+ 0.00%
-+ 0.00%
-+ 0.00%
Pfizer, Apple And 3 Stocks To Watch Heading Into Tuesday
Share
Listen to the news

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Pfizer Inc. (NYSE:PFE) to report quarterly earnings at 72 cents per share on revenue of $15.87 billion before the opening bell, according to data from Benzinga Pro. Pfizer shares rose 1.2% to $31.03 in after-hours trading.
  • Apple Inc. (NASDAQ:AAPL) reported upbeat earnings and revenue for the fourth quarter of fiscal 2026 after the closing bell on Monday. However, the company sees a decline in gross margin for the holiday quarter. Apple shares dropped 2.8% to $328.81 in the after-hours trading session.
  • Analysts are expecting Keurig Dr Pepper Inc. (NASDAQ:KDP) to post earnings of 62 cents per share on revenue of $7.33 billion for the latest quarter. The company will release earnings before the markets open. Keurig Dr Pepper shares rose 1% to $37.18 in after-hours trading.

Check out our premarket coverage here

  • Palantir Technologies Inc. (NASDAQ:PLTR) reported better-than-expected financial results for the third quarter and raised its full-year revenue guidance. Palantir posted third-quarter revenue of $2.31 billion, beating analyst estimates of $2.18 billion. The AI software company reported adjusted earnings of 44 cents per share for the quarter, beating estimates of 41 cents per share, according to Benzinga Pro. Palantir shares fell 3% to $173.00 in the after-hours trading session.
  • Analysts expect Advanced Micro Devices Inc. (NASDAQ:AMD) to post quarterly earnings of $1.95 per share on revenue of $13.09 billion after the closing bell. AMD shares rose 1.1% to $472.00 in after-hours trading.

Photo courtesy: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending